Works in Cancer Immunology, Immunotherapy, 2023, Vol 72, Issue 6

Results: 49
    1
    2
    3

    Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.

    Published in:
    2023
    By:
    • García-Corbacho, Javier;
    • Indacochea, Alberto;
    • González Navarro, Azucena E.;
    • Victoria, Iván;
    • Moreno, Débora;
    • Pesántez, David;
    • Angelats, Laura;
    • Modrego-Sanchez, Andrea;
    • Sanfeliu, Esther;
    • Castillo, Oleguer;
    • Blasco, Paula;
    • Mezquita, Laura;
    • Viñolas, Nuria;
    • Nogué, Miquel;
    • Galván, Patricia;
    • Adamo, Barbara;
    • Basté, Neus;
    • Sauri, Tamara;
    • Juan, Manel;
    • Prat, Aleix
    Publication type:
    Correction Notice
    4
    5
    6
    7
    8
    9

    Human γδ T cells induce CD8<sup>+</sup> T cell antitumor responses via antigen-presenting effect through HSP90-MyD88-mediated activation of JNK.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1803, doi. 10.1007/s00262-023-03375-w
    By:
    • Wang, Shengdong;
    • Li, Hengyuan;
    • Chen, Tao;
    • Zhou, Hao;
    • Zhang, Wenkan;
    • Lin, Nong;
    • Yu, Xiaohua;
    • Lou, Yu;
    • Li, Binghao;
    • Yinwang, Eloy;
    • Wang, Zenan;
    • Wang, Keyi;
    • Xue, Yucheng;
    • Qu, Hao;
    • Lin, Peng;
    • Sun, Hangxiang;
    • Teng, Wangsiyuan;
    • Mou, Haochen;
    • Chai, Xupeng;
    • Cai, Zhijian
    Publication type:
    Article
    10
    11
    12

    Predictive value of p53 and AXL immunostaining for the efficacy of immune checkpoint inhibitor-based therapy after osimertinib treatment in patients with epidermal growth factor-mutant non-small cell lung cancer.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1699, doi. 10.1007/s00262-023-03370-1
    By:
    • Morimoto, Kenji;
    • Yamada, Tadaaki;
    • Sawada, Ryo;
    • Azuma, Koichi;
    • Goto, Yasuhiro;
    • Harada, Taishi;
    • Shiotsu, Shinsuke;
    • Tamiya, Nobuyo;
    • Chihara, Yusuke;
    • Takeda, Takayuki;
    • Hiranuma, Osamu;
    • Hasegawa, Isao;
    • Tanaka, Satomi;
    • Yoshimura, Akihiro;
    • Iwasaku, Masahiro;
    • Tokuda, Shinsaku;
    • Kim, Young Hak;
    • Takayama, Koichi
    Publication type:
    Article
    13
    14
    15

    Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1903, doi. 10.1007/s00262-023-03367-w
    By:
    • Shiota, Masaki;
    • Miyake, Hideaki;
    • Takahashi, Masayuki;
    • Oya, Mototsugu;
    • Tsuchiya, Norihiko;
    • Masumori, Naoya;
    • Matsuyama, Hideyasu;
    • Obara, Wataru;
    • Shinohara, Nobuo;
    • Fujimoto, Kiyohide;
    • Nozawa, Masahiro;
    • Ohba, Kojiro;
    • Ohyama, Chikara;
    • Hashine, Katsuyoshi;
    • Akamatsu, Shusuke;
    • Kamba, Tomomi;
    • Mita, Koji;
    • Gotoh, Momokazu;
    • Tatarano, Shuichi;
    • Fujisawa, Masato
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22

    Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1709, doi. 10.1007/s00262-022-03360-9
    By:
    • García-Corbacho, Javier;
    • Indacochea, Alberto;
    • González Navarro, Azucena E.;
    • Victoria, Iván;
    • Moreno, Débora;
    • Pesántez, David;
    • Angelats, Laura;
    • Modrego-Sanchez, Andrea;
    • Sanfeliu, Esther;
    • Castillo, Oleguer;
    • Blasco, Paula;
    • Mezquita, Laura;
    • Viñolas, Nuria;
    • Nogué, Miquel;
    • Galván, Patricia;
    • Adamo, Barbara;
    • Basté, Neus;
    • Sauri, Tamara;
    • Juan, Manel;
    • Prat, Aleix
    Publication type:
    Article
    23

    Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50%.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1881, doi. 10.1007/s00262-022-03359-2
    By:
    • Pons-Tostivint, E.;
    • Hulo, P.;
    • Guardiolle, V.;
    • Bodot, L.;
    • Rabeau, A.;
    • Porte, M.;
    • Hiret, S.;
    • Demontrond, P.;
    • Curcio, H.;
    • Boudoussier, A.;
    • Veillon, R.;
    • Mayenga, M.;
    • Dumenil, C.;
    • Chatellier, T.;
    • Gourraud, P. A.;
    • Mazieres, J.;
    • Bennouna, J.
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31

    Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1365, doi. 10.1007/s00262-022-03349-4
    By:
    • Santoni, Matteo;
    • Rizzo, Alessandro;
    • Kucharz, Jakub;
    • Mollica, Veronica;
    • Rosellini, Matteo;
    • Marchetti, Andrea;
    • Tassinari, Elisa;
    • Monteiro, Fernando Sabino Marques;
    • Soares, Andrey;
    • Molina-Cerrillo, Javier;
    • Grande, Enrique;
    • Battelli, Nicola;
    • Massari, Francesco
    Publication type:
    Article
    32
    33
    34

    BAP1 and PTEN mutations shape the immunological landscape of clear cell renal cell carcinoma and reveal the intertumoral heterogeneity of T cell suppression: a proof-of-concept study.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1603, doi. 10.1007/s00262-022-03346-7
    By:
    • Friedhoff, Jana;
    • Schneider, Felix;
    • Jurcic, Christina;
    • Endris, Volker;
    • Kirchner, Martina;
    • Sun, Angela;
    • Bolnavu, Iulia;
    • Pohl, Laura;
    • Teroerde, Miriam;
    • Kippenberger, Maximilian;
    • Schwab, Constantin;
    • Kaczorowski, Adam;
    • Zschäbitz, Stefanie;
    • Jäger, Dirk;
    • Hohenfellner, Markus;
    • Stenzinger, Albrecht;
    • Duensing, Anette;
    • Duensing, Stefan
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41

    Cxcr3 constrains pancreatic cancer dissemination through instructing T cell fate.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1461, doi. 10.1007/s00262-022-03338-7
    By:
    • Burrack, Adam L.;
    • Spartz, Ellen J.;
    • Rollins, Meagan R.;
    • Miller, Ebony A.;
    • Firulyova, Maria;
    • Cruz, Eduardo;
    • Goldberg, Michael F.;
    • Wang, Iris X.;
    • Nanda, Hezkiel;
    • Shen, Steven;
    • Zaitsev, Konstantin;
    • Stromnes, Ingunn M.
    Publication type:
    Article
    42
    43
    44
    45

    Anti-4-1BB immunotherapy enhances systemic immune effects of radiotherapy to induce B and T cell-dependent anti-tumor immune activation and improve tumor control at unirradiated sites.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1445, doi. 10.1007/s00262-022-03325-y
    By:
    • Martin, Alexandra L.;
    • Powell, Chase;
    • Nagy, Mate Z.;
    • Innamarato, Patrick;
    • Powers, John;
    • Nichols, Derek;
    • Anadon, Carmen M.;
    • Chaurio, Ricardo A.;
    • Kim, Sungjune;
    • Wang, Min-hsuan;
    • Gong, Bing;
    • Wang, Xianzhe;
    • Scheutz, Thomas J.;
    • Antonia, Scott J.;
    • Conejo-Garcia, Jose R.;
    • Perez, Bradford A.
    Publication type:
    Article
    46
    47
    48

    A phase 1b single-arm trial of intratumoral oncolytic virus V937 in combination with pembrolizumab in patients with advanced melanoma: results from the CAPRA study.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1405, doi. 10.1007/s00262-022-03314-1
    By:
    • Silk, Ann W.;
    • O'Day, Steven J.;
    • Kaufman, Howard L.;
    • Bryan, Jennifer;
    • Norrell, Jacqueline T.;
    • Imbergamo, Casey;
    • Portal, Daniella;
    • Zambrano-Acosta, Edwin;
    • Palmeri, Marisa;
    • Fein, Seymour;
    • Wu, Cai;
    • Guerreiro, Leslie;
    • Medina, Daniel;
    • Bommareddy, Praveen K.;
    • Zloza, Andrew;
    • Fox, Bernard A.;
    • Ballesteros-Merino, Carmen;
    • Ren, Yixin;
    • Shafren, Darren;
    • Grose, Mark
    Publication type:
    Article
    49